z-logo
Premium
Effects of Levodopa Therapy in Patients with Parkinson's Disease: Statistical Evidence for Reduced Tolerance to Levodopa in the Elderly
Author(s) -
GRAD BERNARD,
WENER JOSEPH,
ROSENBERG GILBERT,
WENER STEPHEN W.
Publication year - 1974
Publication title -
journal of the american geriatrics society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.992
H-Index - 232
eISSN - 1532-5415
pISSN - 0002-8614
DOI - 10.1111/j.1532-5415.1974.tb05836.x
Subject(s) - medicine , levodopa , orthostatic vital signs , dose , blood pressure , analysis of variance , anesthesia , sitting , parkinson's disease , surgery , disease , pathology
ABSTRACT: The systolic and diastolic blood pressure (BP), with the patient in the standing, sitting and recumbent positions, and the pulse rate were determined at various time intervals in 51 parkinsonian patients during prolonged levodopa therapy. Hypotension was observed in 10 patients (19.6 per cent). In 5 of these cases it was clinically significant and associated with syncope, so the drug had to be discontinued after two to sixteen weeks of therapy. In the other 5 cases the hypotension was transitory and not clinically significant, so the drug did not have to be discontinued. These 5 cases were included with the 46 cases subjected to statistical analysis. In the 46 cases, both the analysis of variance and the correlation coefficients showed that the dosages of levodopa had no significant effect either on the BP or the pulse. In attempting to produce a clinically significant therapeutic effect with a minimum of toxic effects it was found that a statistically significant lower dosage of levodopa was necessary for the “older” subjects (those over age 70) as compared to the “younger” subjects (those aged 70 or younger). Furthermore, such dosage differences appeared to be more marked in women than in men. In both the normotensive and the hypotensive responses to levodopa, no orthostatic effect was observed nor was there a dose‐related response of the BP within the dosage range used in this study (a maximal level between 2.0 and 4.0 gm daily).

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here